Several studies have shown that NGAL is an early diagnostic biomarker for acute kidney injury (AKI) in common clinical AKI scenarios including contrast nephropathy, cardiac surgery, critical care and transplantation [25-27]. The gene discussed is LCN2; the disease is acute kidney injury.